Steven Fulop
Neurological Surgery · Philadelphia, PANPI 1174721823
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $107,300 of the $139,707 with a category attached, or 76.8%. Stryker accounts for 87.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $64,020 and has fallen 99.8% since, to $152 in 2025. Among neurological surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $1058.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$122K
- Clariance, Inc.$12K
- Surgalign Spine Technologies, Inc.$5K
- Orthofix Medical, Inc.$82
- Medtronic$64
- UCB, Inc.$55
- plus $136 from 6 others
What the payments were for
- Royalty or licence$8,1206%
- Consulting fees$107,30077%
- Speaking & faculty fees$8,0506%
- Travel & lodging$11,3998%
- Food & beverage$4,8373%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 92 | $122,377 |
| Clariance, Inc. | 21 | $12,080 |
| Surgalign Spine Technologies, Inc. | 6 | $4,912 |
| Orthofix Medical, Inc. | 1 | $82 |
| Medtronic | 3 | $64 |
| UCB, Inc. | 3 | $55 |
| GE HealthCare | 1 | $30 |
| SK Life Science, Inc. | 1 | $28 |
| Argenx US, Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRITANIUM$71,420
- ES2$56,419
- SERRATO$40,618
- AERO$36,343
- ES2 SPINAL SYSTEM$26,867
- RAVINE LATERAL ACCESS SYSTEM$18,850
- AIRO$14,300
- AVIATOR$12,350
- XIA$12,350
- OASYS$12,350
- LLIF PLATE$4,698
- FORTILINK$4,500
- CASCADIA$4,275
- EVEREST$4,275
- LITE PLATE SYSTEM$3,332
- CASCADIA INTERBODY SYSTEM$3,189
- MANTIS$2,750
- YUKON$2,000
- ESCALATE$2,000
- NEURO FIXATION$1,786
How this compares
$139,707 in reported general payments places this provider in the 90th percentile of 390 neurological surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 36 | $656 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $220 |
| Meloxicam | 19 | $83 |
| Methylprednisolone | 11 | $67 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Philadelphia
- Amer SamdaniPhiladelphia$4.4M
- Brian JankowitzPhiladelphia$823K
- Joshua HellerPhiladelphia$519K
- Srinivas PrasadPhiladelphia$513K
- Chengyuan WuPhiladelphia$377K
- John ShinPhiladelphia$306K
- Omar ChoudhriPhiladelphia$304K
- Pascal JabbourPhiladelphia$198K
- Casey HalpernPhiladelphia$186K
- Kyle MuellerPhiladelphia$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.